Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended: December 31, 2020 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-35060 PACIRA BIOSCIENCES, INC. (Exact Name of Registrant as Specified in its Charter) (State or Other Jurisdictio ...

Pacira BioSciences, Inc. (NASDAQ:PCRX) Q3 2020 Earnings Conference Call October 29, 2020 8:30 AM ET Company Participants Susan Mesco - Head of Investor Relations David Stack - Chairman & Chief Executive Officer Charlie Reinhart - Chief Financial Officer Conference Call Participants Randall Stanicky - RBC Capital Markets David Amsellem - Piper Sandler David Steinberg - Jefferies Balaji Prasad - Barclays Greg Fraser - Truist Securities Gary Nachman - BMO Serge Belanger - Needham & Company Ami Fadia - SVB Leer ...